论文部分内容阅读
目前,国内红细胞实验室A B O血型鉴定工作主要是利用血型血清学方法,但存在一定缺陷[1]。以DNA为检材的基因分型技术克服了血型血清学方法的限制,已是一种独立简便的分型方法,为临床解决了一些疑难血型鉴定问题,得到广泛应用。从提高输血安全性方面考虑,向临床提供基因定型相符的血液产品是大势所趋,因此,ABO基因分型技术也是红细胞实验室的技术发展方向[2]。笔者研
At present, the identification of A B O blood group in domestic RBC laboratories mainly utilizes the blood group serological method, but it has some defects [1]. The DNA-based genotyping technology overcomes the limitations of blood-based serological methods and is an independent and convenient typing method. It has been widely used in clinic to solve some difficult blood type identification problems. From the perspective of improving the safety of blood transfusion, it is the trend of the times to provide blood products that are clinically appropriate for genotyping. Therefore, ABO genotyping technology is also the development direction of RBC laboratories [2]. I study